Coronavirus Testing Trials -- Professor Sarah Gilbert Interview

Professor Sarah Gilbert explains the composition and mechanism of a new vaccine using an adenovirus vector to deliver the coronavirus spike protein, inducing an immune response. The vaccine is designed to be safe, unable to replicate or cause disease. It triggers both antibody and T cell responses, providing protection against the virus. Gilbert expresses high confidence in the vaccine's effectiveness, based on previous successful studies with similar technology, but emphasizes the need for human testing before widespread use.

What new insight or understanding did you gain from this video?